Conserved Protein Domain Family
MFS_SLC22A17_like

?
cd17373: MFS_SLC22A17_like 
Solute carrier family 22, member 17 and similar proteins of the Major Facilitator Superfamily
This group is composed of Solute carrier family 22, members 17, 23, and 31. They are members of the SLC22 family of organic cation/anion/zwitterion transporters, which includes organic cation transporters (OCTs/OCTNs) and organic anion transporters (OATs). SLC22A17 functions as a cell surface receptor for lipocalin-2 (LCN2), also called NGAL or 24p3, which plays a key role in iron homeostasis and transport. SLC22A23 and SLC22A31 are orphan members of the SLC22 family. SLC22 transporters interact with a variety of compounds that include drugs of abuse, environmental toxins, opioid analgesics, antidepressant and anxiolytic agents, and neurotransmitters and their metabolites. The SLC22A17-like group belongs to the Major Facilitator Superfamily (MFS) of membrane transport proteins, which are thought to function through a single substrate binding site, alternating-access mechanism involving a rocker-switch type of movement.
Statistics
?
PSSM-Id: 340931
Aligned: 3 rows
Threshold Bit Score: 369.539
Created: 29-Feb-2016
Updated: 2-Oct-2020
Structure
?
Aligned Rows:
 
putative
Feature 1:putative chemical substrate binding pocket [chemical binding site]
Evidence:
  • Comment:based on the structures of MFS transporters with bound substrates, substrate analogs, and/or inhibitors
  • Comment:since MFS proteins facilitate the transport of many different substrates including ions, sugar phosphates, drugs, neurotransmitters, nucleosides, amino acids, and peptides, the residues involved in substrate binding may not be strictly conserved among superfamily members
  • Comment:the substrate binding site or translocation pore has access to both sides of the membrane in an alternating fashion through a conformational change of the MFS transporter

Sequence Alignment
?
Format: Row Display: Color Bits: Type Selection:
Feature 1              ##  ##  #                       #                                      
Q8WUG5     74 WDYNGLPVLTTNAIGQWDLVCDlgwqVILEQILFILGFASGYLFLGYPADrfgRRGIVLLTLGLVGPCGVGgaaagsstg 153 human
A6NKX4    103 RPSSWASCSGAAAGPTWNLVCGdgwkVPLEQVSHLLGWLLGCVILGAGCDrfgRRAVFVASLVLTTGLGASealaasfpt 182 human
A1A5C7    203 WDYGIRAGLVQNVVSKWDLVCDnawkVHIAKFSLLVGLIFGYLITGCIADwvgRRPVLLFSIIFILIFGLTvalsvnvtm 282 human
Feature 1                ## ###  #               #  ##  #                                     
Q8WUG5    154 vMALRFLLGFLLAGVDLGVYLMrlelcdptqrlrvALAGELVGVGGHFLFLGLalvskdWRFLQRMITAPCILFLFYGWP 233 human
A6NKX4    183 lLVLRLLHGGTLAGALLALYLArlelcdpphrlafSMGAGLFSVVGTLLLPGLaalvqdWRLLQGLGALMSGLLLLFWGF 262 human
A1A5C7    283 fSTLRFFEGFCLAGIILTLYALrielcppgkrfmiTMVASFVAMAGQFLMPGLaalcrdWQVLQALIICPFLLMLLYWSI 362 human
Feature 1                                                                                     
Q8WUG5    234 GLflesarwlivkrqieeaqsvlrilaernrphgqml----geeaqealqdlentcplpatssfsfasllnyrniwKNLL 309 human
A6NKX4    263 PAlfpespcwllatgqvararkilwrfaeasgvgpgdssleenslatateltmlsarspqpryhsplgllrtrvtwRNGL 342 human
A1A5C7    363 FPeslrwlmatqqfesakrlilhftqknrmnpeg----------dikgvipelekelsrrpkkvcivkvvgtrnlwKNIV 432 human
Feature 1          #  ##  ###  #                         #   #                                
Q8WUG5    310 ILGFTNFIAHAIRHCYQPVGgggsp-----sdfylCSLLASGTAALACVFLGVTVDRFgrrgilLLSMTLTGIASLVLLG 384 human
A6NKX4    343 ILGFSSLVGGGIRASFRRSLapqvp------tfylPYFLEAGLEAAALVFLLLTADCCgrrpvlLLGTMVTGLASLLLLA 416 human
A1A5C7    433 VLCVNSLTGYGIHHCFARSMmghevkvpllenfyaDYYTTASIALVSCLAMCVVVRFLgrrgglLLFMILTALASLLQLG 512 human
Feature 1                                          ##   #   #               #  ##  ##  #      
Q8WUG5    385 LwdcehpifptvwaqqgnpnrdlneaaittfSVLGLFSSQAAAILSTLLAAEVIPTTVRgRGLGLIMALGALGGLSGPAq 464 human
A6NKX4    417 Gaqylpg------------------wtvlflSVLGLLASRAVSALSSLFAAEVFPTVIRgAGLGLVLGAGFLGQAAGPLd 478 human
A1A5C7    513 Llnligkysqhpdsg---msdsvkdkfsiafSIVGMFASHAVGSLSVFFCAEITPTVIRcGGLGLVLASAGFGMLTAPIi 589 human
Feature 1                                   
Q8WUG5    465 rlhmghgaflQHVVLAACALLCILSIMLLP 494 human
A6NKX4    479 tlhgrqgfflQQVVFASLAVLALLCVLLLP 508 human
A1A5C7    590 elhnqkgyflHHIIFACCTLICIICILLLP 619 human

| Disclaimer | Privacy statement | Accessibility |
NCBI Home NCBI Search NCBI SiteMap